Page last updated: 2024-11-13

s-(2-carboxyethyl)cysteine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID23618202
SCHEMBL ID1867969
MeSH IDM0069572

Synonyms (34)

Synonym
einecs 223-717-2
alanine, 3-((2-carboxyethyl)thio)-
l-3-((2-carboxyethyl)thio)alanine
s-(2-carboxyethyl)cysteine
s-(2-carboxyethyl)-l-cysteine
alanine, 3-((2-carboxyethyl)thio)-, l-
brn 1725406
s-2-carboxyethyl-l-cysteine
3-((2-carboxyethyl)thio)alanine
(2r)-2-amino-3-[(2-carboxyethyl)sulfanyl]propanoic acid
AKOS006278622
95ol8j8k17 ,
s-carboxyethyl-l-cysteine
4-04-00-03151 (beilstein handbook reference)
l-cysteine, s-(2-carboxyethyl)-
4033-46-9
unii-95ol8j8k17
s-2-carboxyethyl-2-cys
s-carboxyethyl-cysteine
SCHEMBL1867969
HF-0229
s-carboxyethylcysteine
(2r)-2-amino-3-[(2-carboxyethyl)sulfanyl]-propanoic acid
C2781
3-[(2-carboxyethyl)thio]alanine
mfcd03424208
2-amino-4-thiaheptanedioic acid
3-(2-carboxyethylthio)alanine
DTXSID40193329
CS-0201572
Q27271807
D95423
(2r)-2-amino-3-(2-carboxyethylsulfanyl)propanoic acid
HY-W141774

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dose-response relationship between production of hemoglobin adduct and dose of acrylamide (0."( Monitoring exposure to acrylamide by the determination of S-(2-carboxyethyl)cysteine in hydrolyzed hemoglobin by gas chromatography-mass spectrometry.
Bailey, E; Bird, I; Farmer, PB; Lamb, JH; Peal, JA, 1986
)
0.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.82 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.12 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]